🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, open-label, first-in-human Phase 1 study evaluating...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-03-07
Trial ID
NCT02715284
Treatments Being Tested
The main goals of this study are to learn about the safety of sacituzumab t...
Status
Recruiting
Location
University of Alabama at Birmingham ( Site 0006)
Start Date
2025-04-09
Trial ID
NCT06824467
Researchers are looking for other ways to treat relapsed high-grade serous ...
Status
Recruiting
Location
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0019)
Start Date
2025-04-15
Trial ID
NCT06843447
The purpose of this study is to determine if Olvi-Vec oncolytic immunothera...
Status
Completed
Location
Gynecologic Oncology Associates
Start Date
2016-05
Trial ID
NCT02759588
Treatments Being Tested
To evaluate the efficacy and safety of cardunolizumab in combination with/w...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-22
Trial ID
NCT06292689
Treatments Being Tested
This randomized phase III trial studies the side effects of paclitaxel when...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-04
Trial ID
NCT00803062
This is an open-label, Phase 1b/2 study to determine the recommended dose o...
Status
Suspended
Location
UCLA Jonsson Comprehensive Cancer Center
Start Date
2019-07-29
Trial ID
NCT04042116
This study is researching an investigational drug called marlotamig (REGN70...
Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
Start Date
2020-12-21
Trial ID
NCT04626635
Treatments Being Tested
Researchers are looking for new ways to treat advanced, high-grade ovarian ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-17
Trial ID
NCT07743164
Treatments Being Tested